By that time the cholestasis was more pronounced, and there was slight focal or disseminated fatty degeneration. Neither hepatocellular necrosis nor evidence of reactive inflammation was found (Fig.

"To our knowledge, our study represents the first randomized, global study to report data for an anti-TIGIT monoclonal ...

Immunotherapy has revolutionised the treatment of advanced hepatocellular carcinoma, starting with atezolizumab–bevacizumab superseding sorafenib in the first line. But how have other areas of care ...

Bland canalicular cholestasis is typically associated with minimal hepatocellular inflammation and normal or only slightly elevated aminotransferase levels and is often seen with anabolic steroids ...

The FDA has issued a complete response letter for rivoceranib plus camrelizumab as a first-line treatment for unresectable ...

HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...

Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC) are respectively the first and the second most common pediatric malignant liver tumors. The purpose of this study was to ...

This situation underscores the urgent need to investigate the mechanisms underlying the association between cholestasis and clinical depression. This review provides a comprehensive examination of ...

Hepatocellular carcinoma (HCC), the third leading cause of cancer-related deaths worldwide, remains one of the most ...

Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, accounts for about 75–85% of all liver cancer ...

A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with ...